Top news of the week: 18.03.2021.
Startups
Record funding flowed into cell, gene therapy companies last year
Nearly $20 billion was invested in biotechs developing cell-, gene- and tissue-based treatments in 2020, according to a new report from industry group ARM.
Synthetic Biology Company Amyris Swapped Biofuels For Personal Care, Its Stock Is Up 10-Fold Over The Past Year
The market for sustainable personal care products is booming. Amyris, one of the earliest synthetic biology companies, is launching new brands to ride the wave.
Life Science Washington
Life Science Innovation Northwest is the Pacific Northwest’s largest annual life science conference bringing together investors, public and private life science organizations, research ...
Exploring the Current State of Biopharma Partnerships
One year into the COVID-19 pandemic the world has experienced unprecedented loss and hardship, but – in that year – we’ve seen life science companies do what they do best: make patient ...
Harness Wealth Helps Next Generation Find Financial Advice Amidst IPO Boom
Harness, founded in 2018, bills itself as a matchmaker between investors and advisors, specifically catering to young clients who are aging into a better fiscal position but who lack ...
Elevate Bio raises half a billion dollars to fuel cell, gene therapy expansion
Softbank and Fidelity joined a large group of investors in a $525 million Series C investment into Elevate, a high-powered genetic medicine startup with an unusual business model.
Germany's Merck in fresh investment to make bioreactor gear in France
Germany's Merck KGaA said it would invest 25 million euros ($29.9 million) in Molsheim, France, to make disposable plastic materials for bioreactors, an essential input for COVID-19 vaccine ...
Pfizer CEO Albert Bourla Helped Save The World. Can He Save His Company’s Stock?
Delivering a game-changing vaccine was a sprint. Bourla says delivering returns for Pfizer shareholders is a marathon.